Clinical trial

To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal Volunteers

NCT00946491

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1987-04-01

PhasePHASE1

Study timeline

Study start (unknown)1987-04-01Date precision: month

Registry last updated2017-03-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Psychosisunresolved

Interventions

Haloperidol 10 mg Tablets (Cord Laboratories)DRUG

Haldol 10 mg Tablets (McNeil Pharmaceuticals)DRUG

Sponsors & collaborators

Sandozlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00946491 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.